Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | OpenQ announces openSpend for Physician Payment Sunshine Act ComplianceOpenQ puts easy-to-use aggregate spend management solution into general release
By: openQ, Inc. OpenQ is the industry leader in compliance solutions and key relationship management and research for pharmaceutical, biotech, and medical device companies. Designed to meet the requirements included in America’s Affordable Health Choices Act, along with recent federal and state legislation, openSpend satisfies a vital and imminent need for life science companies. OpenSpend includes the following key capabilities: - Management dashboard - Easy-to- - Wizard- - Contract tracking module - Internal and external reporting with filtering and ad hoc - Configurable workflow and approval management - openQ proprietary research feeds and algorithms for validation, identity matching and legislative updates “Pharmaceutical, medical device and biotech companies can now count on openQ to help them meet another critical compliance need: aggregate spend management,” “When we looked at the aggregate spend space we immediately saw an opportunity to bring the unique combination of market information, expertise and workflow technology to managing caps and disclosure,” About openQ In its sixth year of rapid growth, openQ has offices throughout the United States, Asia, and Europe and a growing client list that spans the globe. The continued interest of life science companies in openQ’s award-winning software and research products for compliance, KOL, speaker, and content management has led them to expand their client base fourfold since 2006. OpenQ serves eight of the top ten pharmaceutical companies and three of the top five medical device companies. For more information, visit www.openq.com. # # # OpenQ provides best practice solutions for successful and compliant KOL relationships and networks, MSL performance and speaker bureau execution. OpenQ provides the next-generation tools, information, and analysis to put your company in the lead. End
Account Email Address Disclaimer Report Abuse
|
|